位置:首页 > 蛋白库 > DHE2_PEPAS
DHE2_PEPAS
ID   DHE2_PEPAS              Reviewed;         421 AA.
AC   P28997;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-1992, sequence version 1.
DT   03-AUG-2022, entry version 93.
DE   RecName: Full=NAD-specific glutamate dehydrogenase;
DE            Short=NAD-GDH;
DE            EC=1.4.1.2 {ECO:0000269|PubMed:17850332};
OS   Peptoniphilus asaccharolyticus (Peptostreptococcus asaccharolyticus).
OC   Bacteria; Firmicutes; Tissierellia; Tissierellales; Peptoniphilaceae;
OC   Peptoniphilus.
OX   NCBI_TaxID=1258;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=ATCC 14963 / DSM 20463 / JCM 1765 / NCIMB 10074 / NCTC 11461 / UW
RC   228;
RX   PubMed=1917850; DOI=10.1128/jb.173.19.6162-6167.1991;
RA   Snedecor B., Chu H., Chen E.Y.;
RT   "Selection, expression, and nucleotide sequencing of the glutamate
RT   dehydrogenase gene of Peptostreptococcus asaccharolyticus.";
RL   J. Bacteriol. 173:6162-6167(1991).
RN   [2]
RP   FUNCTION AS A GLUTAMATE DEHYDROGENASE, CATALYTIC ACTIVITY, MUTAGENESIS OF
RP   GLU-243; TRP-244 AND ASP-245, BIOPHYSICOCHEMICAL PROPERTIES, AND COENZYME
RP   SPECIFICITY.
RC   STRAIN=ATCC 14963 / DSM 20463 / JCM 1765 / NCIMB 10074 / NCTC 11461 / UW
RC   228;
RX   PubMed=17850332; DOI=10.1111/j.1742-4658.2007.06038.x;
RA   Carrigan J.B., Engel P.C.;
RT   "Probing the determinants of coenzyme specificity in Peptostreptococcus
RT   asaccharolyticus glutamate dehydrogenase by site-directed mutagenesis.";
RL   FEBS J. 274:5167-5174(2007).
RN   [3] {ECO:0007744|PDB:2YFQ}
RP   X-RAY CRYSTALLOGRAPHY (2.94 ANGSTROMS), COENZYME SPECIFICITY, MUTAGENESIS
RP   OF GLU-243, AND SUBUNIT.
RX   PubMed=22068154; DOI=10.1016/j.jsb.2011.10.006;
RA   Oliveira T., Panjikar S., Carrigan J.B., Hamza M., Sharkey M.A.,
RA   Engel P.C., Khan A.R.;
RT   "Crystal structure of NAD+-dependent Peptoniphilus asaccharolyticus
RT   glutamate dehydrogenase reveals determinants of cofactor specificity.";
RL   J. Struct. Biol. 177:543-552(2012).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + L-glutamate + NAD(+) = 2-oxoglutarate + H(+) + NADH +
CC         NH4(+); Xref=Rhea:RHEA:15133, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16810, ChEBI:CHEBI:28938, ChEBI:CHEBI:29985,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.4.1.2;
CC         Evidence={ECO:0000269|PubMed:17850332};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=4.4 uM for NAD (at pH 7) {ECO:0000269|PubMed:17850332};
CC         KM=1640 uM for NADP (at pH 7) {ECO:0000269|PubMed:17850332};
CC         Note=These values indicate a 1165-fold discrimination in favor of
CC         NADH.;
CC   -!- PATHWAY: Amino-acid degradation; L-glutamate degradation via
CC       hydroxyglutarate pathway; crotonoyl-CoA from L-glutamate: step 1/5.
CC   -!- SUBUNIT: Homohexamer. {ECO:0000269|PubMed:22068154}.
CC   -!- SIMILARITY: Belongs to the Glu/Leu/Phe/Val dehydrogenases family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M76403; AAA25611.1; -; Genomic_DNA.
DR   PIR; A38168; A38168.
DR   PDB; 2YFQ; X-ray; 2.94 A; A/B=1-421.
DR   PDBsum; 2YFQ; -.
DR   AlphaFoldDB; P28997; -.
DR   SMR; P28997; -.
DR   PRIDE; P28997; -.
DR   BioCyc; MetaCyc:MON-1161; -.
DR   BRENDA; 1.4.1.2; 4665.
DR   UniPathway; UPA00533; UER00591.
DR   GO; GO:0004352; F:glutamate dehydrogenase (NAD+) activity; IMP:UniProtKB.
DR   GO; GO:0006520; P:cellular amino acid metabolic process; IMP:UniProtKB.
DR   GO; GO:0019552; P:glutamate catabolic process via 2-hydroxyglutarate; IEA:UniProtKB-UniPathway.
DR   CDD; cd01076; NAD_bind_1_Glu_DH; 1.
DR   InterPro; IPR046346; Aminiacid_DH-like_N_sf.
DR   InterPro; IPR006095; Glu/Leu/Phe/Val_DH.
DR   InterPro; IPR033524; Glu/Leu/Phe/Val_DH_AS.
DR   InterPro; IPR006096; Glu/Leu/Phe/Val_DH_C.
DR   InterPro; IPR006097; Glu/Leu/Phe/Val_DH_dimer_dom.
DR   InterPro; IPR014362; Glu_DH.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR033922; NAD_bind_Glu_DH.
DR   Pfam; PF00208; ELFV_dehydrog; 1.
DR   Pfam; PF02812; ELFV_dehydrog_N; 1.
DR   PIRSF; PIRSF000185; Glu_DH; 1.
DR   PRINTS; PR00082; GLFDHDRGNASE.
DR   SMART; SM00839; ELFV_dehydrog; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   SUPFAM; SSF53223; SSF53223; 1.
DR   PROSITE; PS00074; GLFV_DEHYDROGENASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; NAD; Oxidoreductase.
FT   CHAIN           1..421
FT                   /note="NAD-specific glutamate dehydrogenase"
FT                   /id="PRO_0000182739"
FT   ACT_SITE        106
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10011"
FT   BINDING         70
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         94
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         191
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250"
FT   BINDING         222
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000250"
FT   BINDING         355
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000250"
FT   SITE            146
FT                   /note="Important for catalysis"
FT                   /evidence="ECO:0000250"
FT   SITE            243
FT                   /note="Important for nucleotide recognition"
FT                   /evidence="ECO:0000269|PubMed:17850332"
FT   MUTAGEN         243
FT                   /note="E->D: Shows a 9-fold relaxation of the strong
FT                   discrimination against NADPH due to the decrease of binding
FT                   affinity for NADH and the increase for NADPH."
FT                   /evidence="ECO:0000269|PubMed:17850332,
FT                   ECO:0000269|PubMed:22068154"
FT   MUTAGEN         243
FT                   /note="E->K: Severely crippled in its ability to bind to
FT                   NADH. Decrease of binding affinity for NADH and increase
FT                   for NADPH."
FT                   /evidence="ECO:0000269|PubMed:17850332,
FT                   ECO:0000269|PubMed:22068154"
FT   MUTAGEN         243
FT                   /note="E->R: Decrease of binding affinity for NADH and
FT                   increase for NADPH."
FT                   /evidence="ECO:0000269|PubMed:17850332,
FT                   ECO:0000269|PubMed:22068154"
FT   MUTAGEN         244
FT                   /note="W->S: Decrease of binding affinity for NADH and
FT                   increase for NADPH."
FT                   /evidence="ECO:0000269|PubMed:17850332"
FT   MUTAGEN         245
FT                   /note="D->K: Decrease of binding affinity for NADH and
FT                   increase for NADPH."
FT                   /evidence="ECO:0000269|PubMed:17850332"
FT   HELIX           7..22
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   HELIX           26..32
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   STRAND          36..47
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   TURN            48..50
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   STRAND          51..61
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   STRAND          65..78
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   HELIX           81..98
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   STRAND          103..110
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   HELIX           113..115
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   HELIX           118..132
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   HELIX           133..135
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   TURN            138..140
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   STRAND          141..145
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   HELIX           151..164
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   TURN            165..167
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   HELIX           171..173
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   HELIX           179..181
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   HELIX           190..205
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   HELIX           210..212
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   STRAND          215..218
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   HELIX           222..233
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   STRAND          238..240
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   STRAND          246..248
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   HELIX           261..271
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   STRAND          296..298
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   HELIX           307..310
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   STRAND          316..319
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   STRAND          322..324
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   HELIX           328..337
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   STRAND          340..342
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   HELIX           344..347
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   HELIX           350..364
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   HELIX           370..394
FT                   /evidence="ECO:0007829|PDB:2YFQ"
FT   HELIX           399..418
FT                   /evidence="ECO:0007829|PDB:2YFQ"
SQ   SEQUENCE   421 AA;  46514 MW;  DDA64241C027422C CRC64;
     MTDTLNPLVA AQEKVRIACE KLGCDPAVYE LLKEPQRVIE ISIPVKMDDG TVKVFKGWRS
     AHSSAVGPSK GGVRFHPNVN MDEVKALSLW MTFKGGALGL PYGGGKGGIC VDPAELSERE
     LEQLSRGWVR GLYKYLGDRI DIPAPDVNTN GQIMSWFVDE YVKLNGERMD IGTFTGKPVA
     FGGSEGRNEA TGFGVAVVVR ESAKRFGIKM EDAKIAVQGF GNVGTFTVKN IERQGGKVCA
     IAEWDRNEGN YALYNENGID FKELLAYKEA NKTLIGFPGA ERITDEEFWT KEYDIIVPAA
     LENVITGERA KTINAKLVCE AANGPTTPEG DKVLTERGIN LTPDILTNSG GVLVSYYEWV
     QNQYGYYWTE AEVEEKQEAD MMKAIKGVFA VADEYNVTLR EAVYMYAIKS IDVAMKLRGW
     Y
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024